Latest Insider Transactions at 2seventy Bio, Inc. (TSVT)
This section provides a real-time view of insider transactions for 2seventy Bio, Inc. (TSVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 2seventy bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 2seventy bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+35.0%
|
-
|
|
Jun 13
2023
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+30.1%
|
-
|
|
Jun 13
2023
|
Ramy Ibrahim |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+30.6%
|
-
|
|
Mar 07
2023
|
Lin Wei |
BUY
Grant, award, or other acquisition
|
Direct |
16,600
+50.0%
|
-
|
|
Feb 13
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
637
-0.3%
|
$7,644
$12.86 P/Share
|
|
Feb 07
2023
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
60
-0.07%
|
$840
$14.7 P/Share
|
|
Feb 01
2023
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
509,821
+20.38%
|
-
|
|
Feb 01
2023
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
132,143
+26.55%
|
-
|
|
Feb 01
2023
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
167,857
+25.77%
|
-
|
|
Jan 12
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
6,587
-1.21%
|
$65,870
$10.46 P/Share
|
|
Jan 11
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
1,077
-1.35%
|
$10,770
$10.63 P/Share
|
|
Jan 11
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
2,026
-0.38%
|
$20,260
$10.63 P/Share
|
|
Jan 11
2023
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
128
-0.14%
|
$1,280
$10.63 P/Share
|
|
Jan 11
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,076
-1.07%
|
$10,760
$10.63 P/Share
|
|
Jan 09
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
2,979
-0.55%
|
$29,790
$10.33 P/Share
|
|
Jan 09
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
3,222
-3.88%
|
$32,220
$10.33 P/Share
|
|
Jan 09
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,794
-3.63%
|
$37,940
$10.33 P/Share
|
|
Jan 09
2023
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
584
-0.65%
|
$5,840
$10.33 P/Share
|
|
Dec 05
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
272
-0.3%
|
$4,080
$15.43 P/Share
|
|
Nov 21
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,697
-7.86%
|
$100,061
$13.97 P/Share
|
|
Aug 05
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
4,152
-4.76%
|
$66,432
$16.23 P/Share
|
|
Aug 05
2022
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,407
-2.25%
|
$38,512
$16.23 P/Share
|
|
Aug 05
2022
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
5,499
-1.0%
|
$87,984
$16.23 P/Share
|
|
Jul 15
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
4,080
-4.47%
|
$53,040
$13.81 P/Share
|
|
Jul 15
2022
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,365
-2.17%
|
$30,745
$13.81 P/Share
|
|
Jul 15
2022
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
5,404
-0.97%
|
$70,252
$13.81 P/Share
|
|
Jun 08
2022
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+36.84%
|
-
|
|
Jun 08
2022
|
Daniel Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+36.27%
|
-
|
|
Jun 08
2022
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
8,200
+42.47%
|
-
|
|
Jun 08
2022
|
Ramy Ibrahim |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+40.34%
|
-
|
|
Jun 08
2022
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+36.84%
|
-
|
|
Mar 17
2022
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
368,857
+39.84%
|
$4,426,284
$12.2 P/Share
|
|
Mar 01
2022
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,750
+26.98%
|
-
|
|
Mar 01
2022
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+30.32%
|
-
|
|
Mar 01
2022
|
Nicola Heffron Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+30.27%
|
-
|
|
Mar 01
2022
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
133,500
+16.2%
|
-
|
|
Feb 17
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
427
-0.74%
|
$5,978
$14.78 P/Share
|
|
Feb 07
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,636
-2.87%
|
$26,176
$16.01 P/Share
|
|
Feb 04
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
467
-0.81%
|
$7,005
$15.41 P/Share
|
|
Jan 07
2022
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
3,270
-1.71%
|
$75,210
$23.91 P/Share
|
|
Jan 07
2022
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,452
-2.3%
|
$33,396
$23.91 P/Share
|
|
Jan 07
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
896
-1.52%
|
$20,608
$23.91 P/Share
|
|
Dec 07
2021
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
257
-0.44%
|
$7,967
$31.06 P/Share
|
|
Nov 11
2021
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,226
+37.39%
|
-
|
|
Nov 11
2021
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
3,002
+50.0%
|
-
|
|
Nov 11
2021
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,009
+38.14%
|
-
|
|
Nov 11
2021
|
Nicola Heffron Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,687
+36.76%
|
-
|
|
Nov 11
2021
|
Ramy Ibrahim |
BUY
Grant, award, or other acquisition
|
Direct |
3,450
+43.36%
|
-
|
|
Nov 11
2021
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109,616
+35.22%
|
-
|
|
Nov 11
2021
|
Daniel Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+33.95%
|
-
|